# To Explore a Single-arm Phase II Study on Intestinal Microbiota Transplantation Combined With Neoadjuvant Immunotherapy and Chemoradiotherapy for Locally Advanced Rectal Cancer Under MSS/pMMR

> clinical trial · VERIFIED · 2026-07-30

Status: NOT_YET_RECRUITING · Sponsor: Tianjin Medical University Cancer Institute and Hospital · Condition: Locally Advanced Rectal Cancer (LARC)

- Company: Tianjin Medical University Cancer Institute and Hospital
- Sector: Locally Advanced Rectal Cancer (LARC)
- Primary source: https://clinicaltrials.gov/study/NCT07738042

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.